Effect of Cytochrome P450 2C9 genetic polymorphism on agomelatine metabolism in vitro

Read full text Summarise with VIRAT
Authors: Ping Fang, Jinhuan Ni, Taoye Shen, Qing Chen, Xinwu Ye, Jia Jin, D. P. Dai, Guoxin Hu, Jianchang Qian, Jianping Cai, Lianguo Chen
Cited by: 0
References: 28

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Genetic polymorphisms of CYP2C9 significantly influence the efficacy and safety of some drugs, which potentially lead to adverse effects and therapeutic failure. The aim of this study was to investigate the genetic polymorphism of 37 CYP2C9 alleles and evaluate their catalytic activities in agomelatine metabolism in vitro . Methods Insect microsomes expressing the 37 recombinant CYP2C9 variants were incubated in a 37 °C water bath with agomelatine. The main active metabolites of agomelatine were detected using a UPLC-MS/MS system. Then, the enzyme kinetic parameters of the 36 variants were calculated and compared with those of the wild-type CYP2C9*1. Results Relative to CYP2C9*1, four variants exhibited no significant difference in enzyme activity. Eleven variants exhibited significantly higher intrinsic clearance values, while 13 variants exhibited significantly reduced intrinsic clearance values. The remaining eight variants demonstrated complex metabolic patterns; these variants do not produce the two metabolites equally, and they inhibited the appearance of one metabolite but promoted the production of another metabolite. These results suggest that special attention should be given to subjects carrying poor metabolizers of CYP2C9 alleles when prescribing agomelatine in clinical practice. This study can provide valuable insights for personalized medicine and reduce adverse reactions to some extent.

Fields of Study & Subjects

Pharmacogenetics and Drug Metabolism Genetic Associations and Epidemiology Drug Transport and Resistance Mechanisms

Publication details

Journal / source
PeerJ
Volume
14
Pages
e20973–e20973
Publication date
19 March 2026
Language
EN